Question

BioMark Lifesystems wanted to enhance the adoption of its new diagnostic substances by medical laboratories. It made an agreement with the dominant producer of syringes and test tubes to have its diagnostic substances sold to laboratories in a package along with the syringes and tubes. This arrangement is known as:

a. sponsorship.

b. product modularity.

c. a bundling relationship.

d. disintermediation.

Answer

This answer is hidden. It contains 1 characters.